Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about XNAS:GOVX

Recent news which mentions XNAS:GOVX

< Previous 1 2 Next >
GeoVax to Raise Approximately $6 Million of Gross Proceeds in Public Offering
Tickers GOVX
Tags en/US GeoVax, Inc/ XNAS:GOVX
From TheNewswire.com - RSS (Media)
GeoVax Announces Issuance of Patent Covering Novel Vaccine Construct for Preventing Malaria Infection
Tickers GOVX
Tags en/US GeoVax, Inc/ XNAS:GOVX
From TheNewswire.com - RSS (Media)
GeoVax Comments on FDA Approval of Keytruda(R) in Head and Neck Cancer, Underscoring Potential for Gedeptin(R) Combination Therapy
Tickers GOVX R
Tags en/US XNAS:GOVX GeoVax, Inc/
From TheNewswire.com - RSS (Media)
GeoVax Highlights Positive Immune Response Results From GEO-CM04S1 in CLL Patients at the European Hematology Association 2025 Meeting
Tickers GOVX
Tags GeoVax, Inc/ XNAS:GOVX en/US
From TheNewswire.com - RSS (Media)
GeoVax Receives Favorable European Regulatory Guidance Supporting Streamlined Development Pathway for GEO-MVA
Tickers GOVX
Tags en/US GeoVax, Inc/ XNAS:GOVX
From TheNewswire.com - RSS (Media)
GeoVax to Participate in BIO International Convention 2025
Tickers GOVX
Tags XNAS:GOVX GeoVax, Inc/ en/US
From TheNewswire.com - RSS (Media)
GeoVax Responds to WHO's Fourth Declaration of Mpox as a Global Public Health Emergency
Tickers GOVX
Tags en/US XNAS:GOVX GeoVax, Inc/
From TheNewswire.com - RSS (Media)
GeoVax Announces Upcoming Presentation at the European Hematology Association 2025 Congress Highlighting Positive Immune Response Data for GEO-CM04S1 in CLL Patients
Tickers GOVX
Tags GeoVax, Inc/ XNAS:GOVX en/US
From TheNewswire.com - RSS (Media)
GeoVax Highlights Broad Cross-Protective Immunity of Multi-Antigen COVID-19 Vaccine Candidates at Keystone Symposia
Tickers GOVX
Tags XNAS:GOVX GeoVax, Inc/ en/US
From TheNewswire.com - RSS (Media)
GeoVax to Showcase Innovative COVID 19 Vaccine Data at the Keystone Symposia on Vaccinology
Tickers GOVX
Tags en/US XNAS:GOVX GeoVax, Inc/
From TheNewswire.com - RSS (Media)
GeoVax Congratulates Bipartisan Senate Action to Onshore Critical Medical Manufacturing
Tickers GOVX
Tags GeoVax, Inc/ XNAS:GOVX en/US
From TheNewswire.com - RSS (Media)
GeoVax Commends FDA's Shift to Risk-Based COVID-19 Vaccination Guidance
Tickers GOVX
Tags en/US GeoVax, Inc/ XNAS:GOVX
From TheNewswire.com - RSS (Media)
GeoVax Applauds EQUIP-A-Pharma Initiative, Reinforces Commitment to Domestic Vaccine Manufacturing and Biodefense Innovation
Tickers GOVX
Tags XNAS:GOVX GeoVax, Inc/ en/US
From TheNewswire.com - RSS (Media)
GeoVax Reaffirms Urgent Need for Multi-Antigen COVID-19 Vaccines as CDC Shifts Recommendations
Tickers GOVX
Tags en/US GeoVax, Inc/ XNAS:GOVX
From TheNewswire.com - RSS (Media)
GeoVax Highlights Dual Protective Potential of GEO-CM04S1 Following Presentation at the AAI Annual Meeting 2025
Tickers GOVX
Tags en/US GeoVax, Inc/ XNAS:GOVX
From TheNewswire.com - RSS (Media)
GeoVax Expands Gedeptin(R) Patent Portfolio
Tickers GOVX R
Tags GeoVax, Inc/ XNAS:GOVX en/US
From TheNewswire.com - RSS (Media)
GeoVax Applauds White House Executive Order Supporting U.S. Pharmaceutical Manufacturing; Highlights Progress in Domestic MVA Vaccine Production
Tickers GOVX
Tags en/US GeoVax, Inc/ XNAS:GOVX
From TheNewswire.com - RSS (Media)
GeoVax Reports First Quarter 2025 Financial Results and Provides Business Update
Tickers GOVX
Tags GeoVax, Inc/ XNAS:GOVX en/US
From TheNewswire.com - RSS (Media)
GeoVax Presents Gedeptin(R) Clinical Data at the American Association for Cancer Research Annual Meeting
Tickers GOVX R
Tags en/US GeoVax, Inc/ XNAS:GOVX
From TheNewswire.com - RSS (Media)
GeoVax Responds to Detection of Clade I Mpox in North Carolina Wastewater
Tickers GOVX
Tags GeoVax, Inc/ XNAS:GOVX en/US
From TheNewswire.com - RSS (Media)
GeoVax Highlights Strong Clinical Results Following Presentation of Multi-Antigen COVID-19 Vaccine at the 25th Annual World Vaccine Congress
Tickers GOVX
Tags en/US GeoVax, Inc/ XNAS:GOVX
From TheNewswire.com - RSS (Media)
GeoVax to Report First Quarter 2025 Financial Results and Provide Corporate Update on May 1, 2025
Tickers GOVX
Tags XNAS:GOVX GeoVax, Inc/ en/US
From TheNewswire.com - RSS (Media)
GeoVax Appoints Dr. Senthil Ranganathan as Vice President, Technical Development and CMC Operations
Tickers GOVX
Tags GeoVax, Inc/ XNAS:GOVX en/US
From TheNewswire.com - RSS (Media)
GeoVax Highlights New Study Demonstrating the Strength of Multi-Antigen COVID-19 Vaccine Candidates
Tickers GOVX
Tags GeoVax, Inc/ XNAS:GOVX en/US
From TheNewswire.com - RSS (Media)
GeoVax Provides Update on BARDA Project NextGen and Outlines 2025 Business Momentum
Tickers GOVX
Tags XNAS:GOVX GeoVax, Inc/ en/US
From TheNewswire.com - RSS (Media)
GeoVax to Present at the Emerging Growth Conference on April 16, 2025
Tickers GOVX
Tags XNAS:GOVX GeoVax, Inc/ en/US
From TheNewswire.com - RSS (Media)
GeoVax to Present Clinical Data at Upcoming April Industry Events
Tickers GOVX
Tags en/US GeoVax, Inc/ XNAS:GOVX
From TheNewswire.com - RSS (Media)
GeoVax Receives USPTO Notice of Allowance for Marburg Hemorrhagic Fever Vaccine Patent
Tickers GOVX
Tags GeoVax, Inc/ XNAS:GOVX en/US
From TheNewswire.com - RSS (Media)
GeoVax Reports 2024 Year-End Financial Results and Provides Business Update
Tickers GOVX
Tags en/US XNAS:GOVX GeoVax, Inc/
From TheNewswire.com - RSS (Media)
GeoVax Labs Announces $4.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Tickers GOVX
Tags en/US XNAS:GOVX GeoVax, Inc/
From TheNewswire.com - RSS (Media)
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS